✦ LIBER ✦

P-546 Phase I/II trial of patupilone once every 3 weeks in patients with non-small cell lung cancer (NSCLC)

✍ Scribed by Østerlind, K.; Sánchez, J.; Zatloukal, P.; Hamm, J.; Belani, C.; Kim, E.; Felip, E.; Sklenar, I.; Berton, M.; John, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1133 POSTER Phase I/II dose-escalation t

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Phase II study with gemcitabine and pacl

✍ Fontaine, C; Joos, G; De Grève, J; De Mey, J; Van Klaveren, R; Neyns, B; Van de 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 106 KB

909 POSTER Phase I/II dose-escalation tr

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 266 KB

100 Phase II study of gemcitabine and ci

✍ Castellano, D.; Lianes, P.; Guerra, J.A.; Gómez-Martín, C.; Paz-Ares, L.; Cortés 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 307 KB

1070 Phase II trial with docetaxel in pa

✍ Latreille, J.; Laberge, F.; Viallet, J.; Maksymiuk, A.; Shepherd, F.; Gelmon, K. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 163 KB

P-251 Randomized phase II trial of weekl

✍ Socinski, Mark A.; Hensing, Thomas A.; Escudero, Miluska; Tynan, Maureen; Baggst 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 340 KB